Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
Titel:
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
Auteur:
Delmas, Pierre D. McClung, Michael R. Zanchetta, José R. Racewicz, Artur Roux, Christian Benhamou, Claude-Laurent Man, Zulema Eusebio, Rachelle A. Beary, John F. Burgio, David E. Matzkin, Ellen Boonen, Steven